“…Glycoprotein2b/3a inhibitors may be considered as an alternative therapy for giant thrombus in LA/LAA. To our knowledge, glycoprotein2b/3a receptor blockers have been used in patients that have undergone percutaneous coronary intervention with a lower rate of bleeding and there are two reports on the successful use of glycoprotein2b/3a inhibitors in patients with mechanical prosthetic valve thrombosis [4,5]. Additionally, Yuce et.…”